Systematic Assessment of Risk of Fever in Solid Tumor Patients Treated With PD-1/PD-L1 Inhibitors: A Systematic Review and Meta-Analysis

Systematic Assessment of Risk of Fever in Solid Tumor Patients Treated With PD-1/PD-L1 Inhibitors: A Systematic Review and Meta-Analysis

Purpose: Drug-induced fever is frequently reported in cancer patients treated with anti-programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1), and stoppage of the offending agent is the management of choice. However, given the complex management of cancer patients, this needs to be c...

Full description

Bibliographic Details
Main Authors: Hongmei Liu, Dongmei Xu, Wentao Wang, Fengchao Sun, Shuisheng Zhang, Xiaowei Yang, Yuan Tian
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
fever
PD-1
PD-L1
solid tumor
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.570080/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.570080/full

Similar Items